By Chris Hutching
Friday 27th October 2000
|Text too small?|
C G Surgical's 10 million shares were issued at 8c recently and Southern Capital bought one million of them. A few early trades last week saw the shares change hands at 60c but this week a parcel of 5000 shares was traded at $1.70.
South Island businessman Mr Paterson, who is a founder shareholder and director of Southern Capital, identified the opportunity to invest in C G Surgical through his links with Otago University researchers.
Other recent fledgling bio-tech companies where Southern Capital has stakes include Blis, which owns patents over a cure for throat infections, and A2 Corporation, which claims patents over milk proteins that may have significance for some health conditions. After initial stagging on Blis and A2 shares issued at 10c, trades have settled to a narrower range around 80c and $2.30, still representing considerable paper profits for Southern Capital.
Managing director Graeme Wong said Southern Capital was retaining its stakes for now.
C G Surgical was developed by engineer Richard Cathro. It has patents over a titanium and teflon clip which prevents pressure on the spinal cord. Pressure can cause neurological-related complaints.
No comments yet
MARKET CLOSE: NZ shares edge up, led by Air NZ and Heartland Bank
NZ dollar slide may be near end with local data likely to show robust labour market
Ports of Auckland buys out Nexus Logistics partner
Forager sees strong share gain for NZME if merger approved, less downside if it isn't
FMA calls Serious Fraud Office into Forestlands probe
UPDATE: Intueri shares fall 52% to 1 cent after company says nothing for shareholders after bank repaid
RBNZ kicks off consultation on capital adequacy review
Cooperative Bank promotes GM customer banking David Cunningham as new boss
NZX first-quarter revenue dips 1.7% as agri sales slide
NZ angel funding hits record $69 million in 2016